474 related articles for article (PubMed ID: 17762512)
1. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
[TBL] [Abstract][Full Text] [Related]
2. Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A
Neuropharmacology; 2007 Apr; 52(5):1274-83. PubMed ID: 17320917
[TBL] [Abstract][Full Text] [Related]
3. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Eur J Pharmacol; 2006 Dec; 553(1-3):185-90. PubMed ID: 17097082
[TBL] [Abstract][Full Text] [Related]
4. Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Wesołowska A; Nikiforuk A; Stachowicz K; Tatarczyńska E
Neuropharmacology; 2006 Sep; 51(3):578-86. PubMed ID: 16828124
[TBL] [Abstract][Full Text] [Related]
5. The anxiolytic-like effect of the selective 5-HT6 receptor antagonist SB-399885: the impact of benzodiazepine receptors.
Wesołowska A
Eur J Pharmacol; 2008 Feb; 580(3):355-60. PubMed ID: 18096153
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity.
Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW
Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092
[TBL] [Abstract][Full Text] [Related]
7. The anxiolytic-like effect of 5-HT1B receptor ligands in rats: a possible mechanism of action.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E
J Pharm Pharmacol; 2005 Feb; 57(2):253-7. PubMed ID: 15720791
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
9. Effect of 5-HT5A antagonists in animal models of schizophrenia, anxiety and depression.
Kassai F; Schlumberger C; Kedves R; Pietraszek M; Jatzke C; Lendvai B; Gyertyán I; Danysz W
Behav Pharmacol; 2012 Aug; 23(4):397-406. PubMed ID: 22785385
[TBL] [Abstract][Full Text] [Related]
10. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
[TBL] [Abstract][Full Text] [Related]
11. Some pharmacological properties of new analogs of MP 3022, the 5-HT1A receptor antagonist.
Chojnacka-Wójcik E; Kłodzińska A; Tatarczyńska E; Paluchowska MH
Pol J Pharmacol; 1999; 51(5):405-13. PubMed ID: 10817541
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
Biała G
Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
[TBL] [Abstract][Full Text] [Related]
14. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict tests.
Jastrzębska-Więsek M; Siwek A; Partyka A; Kubacka M; Mogilski S; Wasik A; Kołaczkowski M; Wesołowska A
Neuropharmacology; 2014 Oct; 85():253-62. PubMed ID: 24905144
[TBL] [Abstract][Full Text] [Related]
16. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
[TBL] [Abstract][Full Text] [Related]
17. Effects of 5-HT6 antagonists, Ro-4368554 and SB-258585, in tests used for the detection of cognitive enhancement and antipsychotic-like activity.
Gravius A; Laszy J; Pietraszek M; Sághy K; Nagel J; Chambon C; Wegener N; Valastro B; Danysz W; Gyertyán I
Behav Pharmacol; 2011 Apr; 22(2):122-35. PubMed ID: 21301322
[TBL] [Abstract][Full Text] [Related]
18. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
Pol J Pharmacol; 2002; 54(6):615-23. PubMed ID: 12866716
[TBL] [Abstract][Full Text] [Related]
19. Diphenyl diselenide exerts anxiolytic-like effect in Wistar rats: putative roles of GABAA and 5HT receptors.
Ghisleni G; Kazlauckas V; Both FL; Pagnussat N; Mioranzza S; Rocha JB; Souza DO; Porciúncula LO
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1508-15. PubMed ID: 18579279
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
Stachowicz K; Gołembiowska K; Sowa M; Nowak G; Chojnacka-Wójcik E; Pilc A
Neuropharmacology; 2007 Nov; 53(6):741-8. PubMed ID: 17870136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]